nodes	percent_of_prediction	percent_of_DWPC	metapath
Prilocaine—Shock—Conjugated Estrogens—prostate cancer	0.00129	0.00165	CcSEcCtD
Prilocaine—Nervous system disorder—Conjugated Estrogens—prostate cancer	0.00129	0.00165	CcSEcCtD
Prilocaine—Hyperhidrosis—Goserelin—prostate cancer	0.00128	0.00164	CcSEcCtD
Prilocaine—Urticaria—Ethinyl Estradiol—prostate cancer	0.00128	0.00164	CcSEcCtD
Prilocaine—Hyperhidrosis—Conjugated Estrogens—prostate cancer	0.00127	0.00162	CcSEcCtD
Prilocaine—Cardiac arrest—Capecitabine—prostate cancer	0.00127	0.00162	CcSEcCtD
Prilocaine—Tension—Estradiol—prostate cancer	0.00126	0.00162	CcSEcCtD
Prilocaine—Dizziness—Bicalutamide—prostate cancer	0.00126	0.00161	CcSEcCtD
Prilocaine—Dysarthria—Doxorubicin—prostate cancer	0.00125	0.0016	CcSEcCtD
Prilocaine—Neuropathy peripheral—Etoposide—prostate cancer	0.00125	0.0016	CcSEcCtD
Prilocaine—Nervousness—Estradiol—prostate cancer	0.00125	0.0016	CcSEcCtD
Prilocaine—Hypotension—Goserelin—prostate cancer	0.00124	0.00159	CcSEcCtD
Prilocaine—Arrhythmia—Mitoxantrone—prostate cancer	0.00123	0.00158	CcSEcCtD
Prilocaine—Hypotension—Conjugated Estrogens—prostate cancer	0.00123	0.00157	CcSEcCtD
Prilocaine—Cardiac failure—Prednisone—prostate cancer	0.00122	0.00156	CcSEcCtD
Prilocaine—Vomiting—Bicalutamide—prostate cancer	0.00121	0.00155	CcSEcCtD
Prilocaine—Tremor—Estradiol—prostate cancer	0.00121	0.00154	CcSEcCtD
Prilocaine—Neuropathy—Epirubicin—prostate cancer	0.0012	0.00154	CcSEcCtD
Prilocaine—Paraesthesia—Goserelin—prostate cancer	0.00119	0.00152	CcSEcCtD
Prilocaine—Osteoarthritis—Prednisone—prostate cancer	0.00119	0.00152	CcSEcCtD
Prilocaine—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.00119	0.00152	CcSEcCtD
Prilocaine—Paraesthesia—Conjugated Estrogens—prostate cancer	0.00118	0.00151	CcSEcCtD
Prilocaine—Somnolence—Goserelin—prostate cancer	0.00118	0.00151	CcSEcCtD
Prilocaine—Bronchospasm—Docetaxel—prostate cancer	0.00117	0.0015	CcSEcCtD
Prilocaine—Somnolence—Conjugated Estrogens—prostate cancer	0.00117	0.00149	CcSEcCtD
Prilocaine—Asthenia—Ethinyl Estradiol—prostate cancer	0.00116	0.00148	CcSEcCtD
Prilocaine—Syncope—Estradiol—prostate cancer	0.00115	0.00148	CcSEcCtD
Prilocaine—Hypoaesthesia—Etoposide—prostate cancer	0.00114	0.00146	CcSEcCtD
Prilocaine—Pain—Goserelin—prostate cancer	0.00113	0.00145	CcSEcCtD
Prilocaine—Bronchospasm—Capecitabine—prostate cancer	0.00113	0.00145	CcSEcCtD
Prilocaine—Nausea—Bicalutamide—prostate cancer	0.00113	0.00145	CcSEcCtD
Prilocaine—Loss of consciousness—Estradiol—prostate cancer	0.00113	0.00145	CcSEcCtD
Prilocaine—Vision blurred—Mitoxantrone—prostate cancer	0.00113	0.00145	CcSEcCtD
Prilocaine—Cardiac arrest—Prednisone—prostate cancer	0.00113	0.00145	CcSEcCtD
Prilocaine—Pain—Conjugated Estrogens—prostate cancer	0.00112	0.00144	CcSEcCtD
Prilocaine—Hypertension—Estradiol—prostate cancer	0.00111	0.00142	CcSEcCtD
Prilocaine—Neuropathy—Doxorubicin—prostate cancer	0.00111	0.00142	CcSEcCtD
Prilocaine—Anaemia—Mitoxantrone—prostate cancer	0.00111	0.00142	CcSEcCtD
Prilocaine—Anxiety—Estradiol—prostate cancer	0.00109	0.0014	CcSEcCtD
Prilocaine—Feeling abnormal—Goserelin—prostate cancer	0.00109	0.0014	CcSEcCtD
Prilocaine—Dizziness—Ethinyl Estradiol—prostate cancer	0.00106	0.00136	CcSEcCtD
Prilocaine—Confusional state—Estradiol—prostate cancer	0.00106	0.00136	CcSEcCtD
Prilocaine—Urticaria—Goserelin—prostate cancer	0.00105	0.00135	CcSEcCtD
Prilocaine—Oedema—Estradiol—prostate cancer	0.00105	0.00134	CcSEcCtD
Prilocaine—Anaphylactic shock—Estradiol—prostate cancer	0.00105	0.00134	CcSEcCtD
Prilocaine—Urticaria—Conjugated Estrogens—prostate cancer	0.00104	0.00133	CcSEcCtD
Prilocaine—Neuropathy peripheral—Docetaxel—prostate cancer	0.00104	0.00133	CcSEcCtD
Prilocaine—Hypertension—Mitoxantrone—prostate cancer	0.00104	0.00133	CcSEcCtD
Prilocaine—Shock—Estradiol—prostate cancer	0.00103	0.00132	CcSEcCtD
Prilocaine—Nervous system disorder—Estradiol—prostate cancer	0.00103	0.00132	CcSEcCtD
Prilocaine—Vomiting—Ethinyl Estradiol—prostate cancer	0.00102	0.00131	CcSEcCtD
Prilocaine—Anxiety—Mitoxantrone—prostate cancer	0.00102	0.0013	CcSEcCtD
Prilocaine—Hyperhidrosis—Estradiol—prostate cancer	0.00102	0.0013	CcSEcCtD
Prilocaine—Neuropathy peripheral—Capecitabine—prostate cancer	0.00101	0.00129	CcSEcCtD
Prilocaine—Confusional state—Mitoxantrone—prostate cancer	0.000987	0.00126	CcSEcCtD
Prilocaine—Oedema—Mitoxantrone—prostate cancer	0.000979	0.00125	CcSEcCtD
Prilocaine—Anaphylactic shock—Mitoxantrone—prostate cancer	0.000979	0.00125	CcSEcCtD
Prilocaine—Hypersensitivity—Goserelin—prostate cancer	0.000976	0.00125	CcSEcCtD
Prilocaine—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000967	0.00124	CcSEcCtD
Prilocaine—Shock—Mitoxantrone—prostate cancer	0.000963	0.00123	CcSEcCtD
Prilocaine—Anaphylactoid reaction—Epirubicin—prostate cancer	0.000959	0.00123	CcSEcCtD
Prilocaine—Nausea—Ethinyl Estradiol—prostate cancer	0.000956	0.00122	CcSEcCtD
Prilocaine—Cardiac failure—Epirubicin—prostate cancer	0.000951	0.00122	CcSEcCtD
Prilocaine—Asthenia—Goserelin—prostate cancer	0.000951	0.00122	CcSEcCtD
Prilocaine—Hypoaesthesia—Docetaxel—prostate cancer	0.000948	0.00121	CcSEcCtD
Prilocaine—Hyperhidrosis—Mitoxantrone—prostate cancer	0.000946	0.00121	CcSEcCtD
Prilocaine—Paraesthesia—Estradiol—prostate cancer	0.000943	0.00121	CcSEcCtD
Prilocaine—Asthenia—Conjugated Estrogens—prostate cancer	0.000942	0.00121	CcSEcCtD
Prilocaine—Bradycardia—Capecitabine—prostate cancer	0.000939	0.0012	CcSEcCtD
Prilocaine—Somnolence—Estradiol—prostate cancer	0.000934	0.0012	CcSEcCtD
Prilocaine—Diplopia—Epirubicin—prostate cancer	0.000928	0.00119	CcSEcCtD
Prilocaine—Osteoarthritis—Epirubicin—prostate cancer	0.000928	0.00119	CcSEcCtD
Prilocaine—Anaemia—Etoposide—prostate cancer	0.000922	0.00118	CcSEcCtD
Prilocaine—Hypoaesthesia—Capecitabine—prostate cancer	0.000917	0.00117	CcSEcCtD
Prilocaine—Hypotension—Mitoxantrone—prostate cancer	0.000915	0.00117	CcSEcCtD
Prilocaine—Pain—Estradiol—prostate cancer	0.000898	0.00115	CcSEcCtD
Prilocaine—Neuropathy peripheral—Prednisone—prostate cancer	0.000897	0.00115	CcSEcCtD
Prilocaine—Anaphylactoid reaction—Doxorubicin—prostate cancer	0.000888	0.00114	CcSEcCtD
Prilocaine—Cardiac arrest—Epirubicin—prostate cancer	0.000883	0.00113	CcSEcCtD
Prilocaine—Cardiac failure—Doxorubicin—prostate cancer	0.00088	0.00113	CcSEcCtD
Prilocaine—Paraesthesia—Mitoxantrone—prostate cancer	0.000879	0.00113	CcSEcCtD
Prilocaine—Loss of consciousness—Etoposide—prostate cancer	0.000877	0.00112	CcSEcCtD
Prilocaine—Dizziness—Goserelin—prostate cancer	0.000876	0.00112	CcSEcCtD
Prilocaine—Somnolence—Mitoxantrone—prostate cancer	0.00087	0.00111	CcSEcCtD
Prilocaine—Dizziness—Conjugated Estrogens—prostate cancer	0.000868	0.00111	CcSEcCtD
Prilocaine—Feeling abnormal—Estradiol—prostate cancer	0.000866	0.00111	CcSEcCtD
Prilocaine—Hypertension—Etoposide—prostate cancer	0.000861	0.0011	CcSEcCtD
Prilocaine—Tinnitus—Capecitabine—prostate cancer	0.00086	0.0011	CcSEcCtD
Prilocaine—Diplopia—Doxorubicin—prostate cancer	0.000859	0.0011	CcSEcCtD
Prilocaine—Osteoarthritis—Doxorubicin—prostate cancer	0.000859	0.0011	CcSEcCtD
Prilocaine—Arrhythmia—Docetaxel—prostate cancer	0.000851	0.00109	CcSEcCtD
Prilocaine—Vomiting—Goserelin—prostate cancer	0.000842	0.00108	CcSEcCtD
Prilocaine—Pain—Mitoxantrone—prostate cancer	0.000837	0.00107	CcSEcCtD
Prilocaine—Bradycardia—Prednisone—prostate cancer	0.000836	0.00107	CcSEcCtD
Prilocaine—Vomiting—Conjugated Estrogens—prostate cancer	0.000834	0.00107	CcSEcCtD
Prilocaine—Urticaria—Estradiol—prostate cancer	0.000834	0.00107	CcSEcCtD
Prilocaine—Arrhythmia—Capecitabine—prostate cancer	0.000824	0.00105	CcSEcCtD
Prilocaine—Confusional state—Etoposide—prostate cancer	0.000821	0.00105	CcSEcCtD
Prilocaine—Cardiac arrest—Doxorubicin—prostate cancer	0.000817	0.00105	CcSEcCtD
Prilocaine—Anaphylactic shock—Etoposide—prostate cancer	0.000814	0.00104	CcSEcCtD
Prilocaine—Feeling abnormal—Mitoxantrone—prostate cancer	0.000807	0.00103	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—EZR—prostate cancer	0.000802	0.00366	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—RRAS—prostate cancer	0.000799	0.00365	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—PRNP—prostate cancer	0.000789	0.0036	CbGpPWpGaD
Prilocaine—SCN2A—L1CAM interactions—MAP2K1—prostate cancer	0.000788	0.0036	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—RRAS—prostate cancer	0.000787	0.0036	CbGpPWpGaD
Prilocaine—Nausea—Goserelin—prostate cancer	0.000787	0.00101	CcSEcCtD
Prilocaine—Hyperhidrosis—Etoposide—prostate cancer	0.000787	0.00101	CcSEcCtD
Prilocaine—Nausea—Conjugated Estrogens—prostate cancer	0.00078	0.000998	CcSEcCtD
Prilocaine—Urticaria—Mitoxantrone—prostate cancer	0.000778	0.000995	CcSEcCtD
Prilocaine—Hypersensitivity—Estradiol—prostate cancer	0.000774	0.000991	CcSEcCtD
Prilocaine—SCN5A—L1CAM interactions—ITGB3—prostate cancer	0.000771	0.00352	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—IL1RN—prostate cancer	0.00077	0.00352	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—EZR—prostate cancer	0.00077	0.00352	CbGpPWpGaD
Prilocaine—Anaemia—Docetaxel—prostate cancer	0.000766	0.000981	CcSEcCtD
Prilocaine—Hypotension—Etoposide—prostate cancer	0.000761	0.000974	CcSEcCtD
Prilocaine—SCN1A—L1CAM interactions—MAP2K1—prostate cancer	0.00076	0.00347	CbGpPWpGaD
Prilocaine—Vision blurred—Capecitabine—prostate cancer	0.000756	0.000968	CcSEcCtD
Prilocaine—Asthenia—Estradiol—prostate cancer	0.000754	0.000965	CcSEcCtD
Prilocaine—Tremor—Capecitabine—prostate cancer	0.000752	0.000963	CcSEcCtD
Prilocaine—Syncope—Docetaxel—prostate cancer	0.000743	0.000952	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—EZR—prostate cancer	0.000743	0.00339	CbGpPWpGaD
Prilocaine—Anaemia—Capecitabine—prostate cancer	0.000742	0.00095	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—PLXNB1—prostate cancer	0.000741	0.00339	CbGpPWpGaD
Prilocaine—Arrhythmia—Prednisone—prostate cancer	0.000734	0.000939	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—NRP1—prostate cancer	0.000733	0.00335	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—HNF1B—prostate cancer	0.000733	0.00335	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—EZR—prostate cancer	0.000732	0.00334	CbGpPWpGaD
Prilocaine—Paraesthesia—Etoposide—prostate cancer	0.000731	0.000936	CcSEcCtD
Prilocaine—Loss of consciousness—Docetaxel—prostate cancer	0.000729	0.000933	CcSEcCtD
Prilocaine—Somnolence—Etoposide—prostate cancer	0.000724	0.000927	CcSEcCtD
Prilocaine—Hypersensitivity—Mitoxantrone—prostate cancer	0.000721	0.000923	CcSEcCtD
Prilocaine—Syncope—Capecitabine—prostate cancer	0.00072	0.000921	CcSEcCtD
Prilocaine—Hypertension—Docetaxel—prostate cancer	0.000716	0.000916	CcSEcCtD
Prilocaine—Drowsiness—Epirubicin—prostate cancer	0.000716	0.000916	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—ESR2—prostate cancer	0.000714	0.00326	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—TH—prostate cancer	0.000709	0.00324	CbGpPWpGaD
Prilocaine—Loss of consciousness—Capecitabine—prostate cancer	0.000705	0.000903	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—HNF1B—prostate cancer	0.000704	0.00322	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—NRP1—prostate cancer	0.000704	0.00322	CbGpPWpGaD
Prilocaine—Asthenia—Mitoxantrone—prostate cancer	0.000702	0.000899	CcSEcCtD
Prilocaine—Neuropathy peripheral—Epirubicin—prostate cancer	0.000701	0.000898	CcSEcCtD
Prilocaine—Pain—Etoposide—prostate cancer	0.000696	0.000891	CcSEcCtD
Prilocaine—Dizziness—Estradiol—prostate cancer	0.000695	0.000889	CcSEcCtD
Prilocaine—Hypertension—Capecitabine—prostate cancer	0.000693	0.000887	CcSEcCtD
Prilocaine—Sweating—Epirubicin—prostate cancer	0.000686	0.000878	CcSEcCtD
Prilocaine—Confusional state—Docetaxel—prostate cancer	0.000682	0.000873	CcSEcCtD
Prilocaine—Anxiety—Capecitabine—prostate cancer	0.000681	0.000872	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—HNF1B—prostate cancer	0.000679	0.0031	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—NRP1—prostate cancer	0.000679	0.0031	CbGpPWpGaD
Prilocaine—Anaphylactic shock—Docetaxel—prostate cancer	0.000677	0.000866	CcSEcCtD
Prilocaine—Oedema—Docetaxel—prostate cancer	0.000677	0.000866	CcSEcCtD
Prilocaine—Vision blurred—Prednisone—prostate cancer	0.000674	0.000863	CcSEcCtD
Prilocaine—Feeling abnormal—Etoposide—prostate cancer	0.000671	0.000859	CcSEcCtD
Prilocaine—SCN5A—Axon guidance—NRP1—prostate cancer	0.000669	0.00306	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—EGR1—prostate cancer	0.000668	0.00305	CbGpPWpGaD
Prilocaine—Vomiting—Estradiol—prostate cancer	0.000668	0.000855	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—EPHB2—prostate cancer	0.000667	0.00305	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—HSP90AB1—prostate cancer	0.000667	0.00305	CbGpPWpGaD
Prilocaine—Shock—Docetaxel—prostate cancer	0.000666	0.000852	CcSEcCtD
Prilocaine—Nervous system disorder—Docetaxel—prostate cancer	0.000663	0.000849	CcSEcCtD
Prilocaine—Drowsiness—Doxorubicin—prostate cancer	0.000662	0.000848	CcSEcCtD
Prilocaine—Anaemia—Prednisone—prostate cancer	0.000661	0.000846	CcSEcCtD
Prilocaine—Confusional state—Capecitabine—prostate cancer	0.00066	0.000846	CcSEcCtD
Prilocaine—Oedema—Capecitabine—prostate cancer	0.000655	0.000839	CcSEcCtD
Prilocaine—Bradycardia—Epirubicin—prostate cancer	0.000654	0.000837	CcSEcCtD
Prilocaine—Neuropathy peripheral—Doxorubicin—prostate cancer	0.000649	0.000831	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—FARP2—prostate cancer	0.000648	0.00296	CbGpPWpGaD
Prilocaine—Urticaria—Etoposide—prostate cancer	0.000647	0.000828	CcSEcCtD
Prilocaine—Shock—Capecitabine—prostate cancer	0.000644	0.000825	CcSEcCtD
Prilocaine—Nervous system disorder—Capecitabine—prostate cancer	0.000642	0.000822	CcSEcCtD
Prilocaine—Syncope—Prednisone—prostate cancer	0.000641	0.000821	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—HSP90AB1—prostate cancer	0.000641	0.00293	CbGpPWpGaD
Prilocaine—Hypoaesthesia—Epirubicin—prostate cancer	0.000639	0.000818	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—GJA1—prostate cancer	0.000636	0.00291	CbGpPWpGaD
Prilocaine—Sweating—Doxorubicin—prostate cancer	0.000635	0.000813	CcSEcCtD
Prilocaine—Hyperhidrosis—Capecitabine—prostate cancer	0.000633	0.000811	CcSEcCtD
Prilocaine—Hypotension—Docetaxel—prostate cancer	0.000632	0.000809	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—AR—prostate cancer	0.000631	0.00288	CbGpPWpGaD
Prilocaine—Loss of consciousness—Prednisone—prostate cancer	0.000628	0.000804	CcSEcCtD
Prilocaine—Nausea—Estradiol—prostate cancer	0.000624	0.000799	CcSEcCtD
Prilocaine—Vomiting—Mitoxantrone—prostate cancer	0.000622	0.000797	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—HSP90AB1—prostate cancer	0.000618	0.00282	CbGpPWpGaD
Prilocaine—Hypertension—Prednisone—prostate cancer	0.000617	0.00079	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—PAK6—prostate cancer	0.000614	0.00281	CbGpPWpGaD
Prilocaine—Hypotension—Capecitabine—prostate cancer	0.000612	0.000784	CcSEcCtD
Prilocaine—SCN5A—Axon guidance—HSP90AB1—prostate cancer	0.000609	0.00278	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—PRNP—prostate cancer	0.000608	0.00278	CbGpPWpGaD
Prilocaine—Paraesthesia—Docetaxel—prostate cancer	0.000608	0.000778	CcSEcCtD
Prilocaine—Anxiety—Prednisone—prostate cancer	0.000607	0.000777	CcSEcCtD
Prilocaine—Bradycardia—Doxorubicin—prostate cancer	0.000605	0.000775	CcSEcCtD
Prilocaine—Somnolence—Docetaxel—prostate cancer	0.000601	0.00077	CcSEcCtD
Prilocaine—Hypersensitivity—Etoposide—prostate cancer	0.0006	0.000768	CcSEcCtD
Prilocaine—Tinnitus—Epirubicin—prostate cancer	0.000599	0.000767	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—MED12—prostate cancer	0.000598	0.00273	CbGpPWpGaD
Prilocaine—Hypoaesthesia—Doxorubicin—prostate cancer	0.000591	0.000757	CcSEcCtD
Prilocaine—Paraesthesia—Capecitabine—prostate cancer	0.000588	0.000753	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—LAMC1—prostate cancer	0.000586	0.00268	CbGpPWpGaD
Prilocaine—Asthenia—Etoposide—prostate cancer	0.000584	0.000748	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—PRNP—prostate cancer	0.000584	0.00267	CbGpPWpGaD
Prilocaine—Anaphylactic shock—Prednisone—prostate cancer	0.000583	0.000747	CcSEcCtD
Prilocaine—Oedema—Prednisone—prostate cancer	0.000583	0.000747	CcSEcCtD
Prilocaine—Nausea—Mitoxantrone—prostate cancer	0.000581	0.000744	CcSEcCtD
Prilocaine—Pain—Docetaxel—prostate cancer	0.000579	0.000741	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—MED12—prostate cancer	0.000574	0.00262	CbGpPWpGaD
Prilocaine—Shock—Prednisone—prostate cancer	0.000574	0.000735	CcSEcCtD
Prilocaine—Arrhythmia—Epirubicin—prostate cancer	0.000574	0.000735	CcSEcCtD
Prilocaine—Nervous system disorder—Prednisone—prostate cancer	0.000572	0.000733	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—NCOA3—prostate cancer	0.000571	0.00261	CbGpPWpGaD
Prilocaine—SCN3A—L1CAM interactions—SRC—prostate cancer	0.000569	0.0026	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—PRKCQ—prostate cancer	0.000568	0.0026	CbGpPWpGaD
Prilocaine—Hyperhidrosis—Prednisone—prostate cancer	0.000564	0.000722	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—PRNP—prostate cancer	0.000563	0.00257	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—RRAS—prostate cancer	0.000562	0.00257	CbGpPWpGaD
Prilocaine—Pain—Capecitabine—prostate cancer	0.00056	0.000717	CcSEcCtD
Prilocaine—Feeling abnormal—Docetaxel—prostate cancer	0.000558	0.000714	CcSEcCtD
Prilocaine—SCN5A—Axon guidance—PRNP—prostate cancer	0.000555	0.00253	CbGpPWpGaD
Prilocaine—Tinnitus—Doxorubicin—prostate cancer	0.000554	0.000709	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—MED12—prostate cancer	0.000554	0.00253	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—IL10—prostate cancer	0.000551	0.00252	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—NCOA3—prostate cancer	0.000549	0.00251	CbGpPWpGaD
Prilocaine—Tension—Epirubicin—prostate cancer	0.000549	0.000702	CcSEcCtD
Prilocaine—SCN2A—L1CAM interactions—SRC—prostate cancer	0.000547	0.0025	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—PRKCQ—prostate cancer	0.000546	0.00249	CbGpPWpGaD
Prilocaine—Nervousness—Epirubicin—prostate cancer	0.000543	0.000695	CcSEcCtD
Prilocaine—Feeling abnormal—Capecitabine—prostate cancer	0.00054	0.000691	CcSEcCtD
Prilocaine—Dizziness—Etoposide—prostate cancer	0.000538	0.000689	CcSEcCtD
Prilocaine—SCN5A—L1CAM interactions—MAP2K1—prostate cancer	0.000534	0.00244	CbGpPWpGaD
Prilocaine—SCN5A—Cardiac Progenitor Differentiation—TGFB1—prostate cancer	0.000533	0.00244	CbGpPWpGaD
Prilocaine—Arrhythmia—Doxorubicin—prostate cancer	0.000531	0.00068	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—NCOA3—prostate cancer	0.000529	0.00242	CbGpPWpGaD
Prilocaine—SCN1A—L1CAM interactions—SRC—prostate cancer	0.000527	0.00241	CbGpPWpGaD
Prilocaine—Vision blurred—Epirubicin—prostate cancer	0.000527	0.000675	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—PRKCQ—prostate cancer	0.000526	0.0024	CbGpPWpGaD
Prilocaine—Paraesthesia—Prednisone—prostate cancer	0.000524	0.000671	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—EZR—prostate cancer	0.000522	0.00239	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—VAV3—prostate cancer	0.000521	0.00238	CbGpPWpGaD
Prilocaine—Urticaria—Capecitabine—prostate cancer	0.00052	0.000666	CcSEcCtD
Prilocaine—Vomiting—Etoposide—prostate cancer	0.000518	0.000663	CcSEcCtD
Prilocaine—Anaemia—Epirubicin—prostate cancer	0.000517	0.000662	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—NR3C1—prostate cancer	0.00051	0.00233	CbGpPWpGaD
Prilocaine—Tension—Doxorubicin—prostate cancer	0.000508	0.00065	CcSEcCtD
Prilocaine—Nervousness—Doxorubicin—prostate cancer	0.000502	0.000643	CcSEcCtD
Prilocaine—Syncope—Epirubicin—prostate cancer	0.000501	0.000642	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—VAV3—prostate cancer	0.0005	0.00229	CbGpPWpGaD
Prilocaine—SCN3A—L1CAM interactions—EGFR—prostate cancer	0.000499	0.00228	CbGpPWpGaD
Prilocaine—Hypersensitivity—Docetaxel—prostate cancer	0.000498	0.000638	CcSEcCtD
Prilocaine—Loss of consciousness—Epirubicin—prostate cancer	0.000491	0.000629	CcSEcCtD
Prilocaine—Vision blurred—Doxorubicin—prostate cancer	0.000488	0.000624	CcSEcCtD
Prilocaine—Asthenia—Docetaxel—prostate cancer	0.000485	0.000621	CcSEcCtD
Prilocaine—Nausea—Etoposide—prostate cancer	0.000484	0.000619	CcSEcCtD
Prilocaine—Hypertension—Epirubicin—prostate cancer	0.000483	0.000618	CcSEcCtD
Prilocaine—Hypersensitivity—Capecitabine—prostate cancer	0.000483	0.000618	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—VAV3—prostate cancer	0.000483	0.0022	CbGpPWpGaD
Prilocaine—Feeling abnormal—Prednisone—prostate cancer	0.000481	0.000616	CcSEcCtD
Prilocaine—SCN2A—L1CAM interactions—EGFR—prostate cancer	0.000479	0.00219	CbGpPWpGaD
Prilocaine—Anaemia—Doxorubicin—prostate cancer	0.000478	0.000612	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—NRP1—prostate cancer	0.000478	0.00218	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—HNF1B—prostate cancer	0.000478	0.00218	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—NCOA2—prostate cancer	0.000477	0.00218	CbGpPWpGaD
Prilocaine—Anxiety—Epirubicin—prostate cancer	0.000474	0.000607	CcSEcCtD
Prilocaine—Asthenia—Capecitabine—prostate cancer	0.00047	0.000602	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—HIF1A—prostate cancer	0.000465	0.00212	CbGpPWpGaD
Prilocaine—Syncope—Doxorubicin—prostate cancer	0.000464	0.000594	CcSEcCtD
Prilocaine—Urticaria—Prednisone—prostate cancer	0.000464	0.000593	CcSEcCtD
Prilocaine—SCN1A—L1CAM interactions—EGFR—prostate cancer	0.000462	0.00211	CbGpPWpGaD
Prilocaine—Confusional state—Epirubicin—prostate cancer	0.00046	0.000589	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—NCOA2—prostate cancer	0.000458	0.00209	CbGpPWpGaD
Prilocaine—Oedema—Epirubicin—prostate cancer	0.000456	0.000584	CcSEcCtD
Prilocaine—Anaphylactic shock—Epirubicin—prostate cancer	0.000456	0.000584	CcSEcCtD
Prilocaine—Loss of consciousness—Doxorubicin—prostate cancer	0.000455	0.000582	CcSEcCtD
Prilocaine—Shock—Epirubicin—prostate cancer	0.000449	0.000575	CcSEcCtD
Prilocaine—Nervous system disorder—Epirubicin—prostate cancer	0.000448	0.000573	CcSEcCtD
Prilocaine—Dizziness—Docetaxel—prostate cancer	0.000447	0.000573	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—ITGB3—prostate cancer	0.000447	0.00204	CbGpPWpGaD
Prilocaine—Hypertension—Doxorubicin—prostate cancer	0.000447	0.000572	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—NCOA2—prostate cancer	0.000442	0.00202	CbGpPWpGaD
Prilocaine—Hyperhidrosis—Epirubicin—prostate cancer	0.000441	0.000565	CcSEcCtD
Prilocaine—Anxiety—Doxorubicin—prostate cancer	0.000439	0.000562	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—HSP90AB1—prostate cancer	0.000434	0.00199	CbGpPWpGaD
Prilocaine—Dizziness—Capecitabine—prostate cancer	0.000433	0.000555	CcSEcCtD
Prilocaine—Vomiting—Docetaxel—prostate cancer	0.00043	0.000551	CcSEcCtD
Prilocaine—Hypersensitivity—Prednisone—prostate cancer	0.00043	0.00055	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—ITGB3—prostate cancer	0.00043	0.00196	CbGpPWpGaD
Prilocaine—Hypotension—Epirubicin—prostate cancer	0.000426	0.000546	CcSEcCtD
Prilocaine—Confusional state—Doxorubicin—prostate cancer	0.000426	0.000545	CcSEcCtD
Prilocaine—Oedema—Doxorubicin—prostate cancer	0.000422	0.000541	CcSEcCtD
Prilocaine—Anaphylactic shock—Doxorubicin—prostate cancer	0.000422	0.000541	CcSEcCtD
Prilocaine—Asthenia—Prednisone—prostate cancer	0.000419	0.000536	CcSEcCtD
Prilocaine—Vomiting—Capecitabine—prostate cancer	0.000416	0.000533	CcSEcCtD
Prilocaine—Shock—Doxorubicin—prostate cancer	0.000415	0.000532	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—ITGB3—prostate cancer	0.000414	0.00189	CbGpPWpGaD
Prilocaine—Nervous system disorder—Doxorubicin—prostate cancer	0.000414	0.00053	CcSEcCtD
Prilocaine—Paraesthesia—Epirubicin—prostate cancer	0.00041	0.000525	CcSEcCtD
Prilocaine—Hyperhidrosis—Doxorubicin—prostate cancer	0.000408	0.000523	CcSEcCtD
Prilocaine—Somnolence—Epirubicin—prostate cancer	0.000406	0.000519	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—PRKCQ—prostate cancer	0.000405	0.00185	CbGpPWpGaD
Prilocaine—Nausea—Docetaxel—prostate cancer	0.000402	0.000514	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—NCOA1—prostate cancer	0.000402	0.00184	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—PRNP—prostate cancer	0.000396	0.00181	CbGpPWpGaD
Prilocaine—Hypotension—Doxorubicin—prostate cancer	0.000395	0.000505	CcSEcCtD
Prilocaine—Pain—Epirubicin—prostate cancer	0.00039	0.0005	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—PRKCQ—prostate cancer	0.000389	0.00178	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MED12—prostate cancer	0.000389	0.00178	CbGpPWpGaD
Prilocaine—Nausea—Capecitabine—prostate cancer	0.000389	0.000498	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—NCOA1—prostate cancer	0.000386	0.00176	CbGpPWpGaD
Prilocaine—Dizziness—Prednisone—prostate cancer	0.000386	0.000494	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—FGF10—prostate cancer	0.000385	0.00176	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—RXRA—prostate cancer	0.000382	0.00175	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—KDR—prostate cancer	0.00038	0.00174	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—CREBBP—prostate cancer	0.00038	0.00173	CbGpPWpGaD
Prilocaine—Paraesthesia—Doxorubicin—prostate cancer	0.000379	0.000485	CcSEcCtD
Prilocaine—Feeling abnormal—Epirubicin—prostate cancer	0.000376	0.000481	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—PRKCQ—prostate cancer	0.000376	0.00172	CbGpPWpGaD
Prilocaine—Somnolence—Doxorubicin—prostate cancer	0.000375	0.000481	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—NCOA1—prostate cancer	0.000372	0.0017	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—NCOA3—prostate cancer	0.000372	0.0017	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—VAV3—prostate cancer	0.000372	0.0017	CbGpPWpGaD
Prilocaine—Vomiting—Prednisone—prostate cancer	0.000371	0.000475	CcSEcCtD
Prilocaine—SCN5A—L1CAM interactions—SRC—prostate cancer	0.000371	0.00169	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—FGF10—prostate cancer	0.00037	0.00169	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—PRKCQ—prostate cancer	0.00037	0.00169	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—RXRA—prostate cancer	0.000367	0.00168	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—KDR—prostate cancer	0.000365	0.00167	CbGpPWpGaD
Prilocaine—Urticaria—Epirubicin—prostate cancer	0.000363	0.000464	CcSEcCtD
Prilocaine—Pain—Doxorubicin—prostate cancer	0.000361	0.000462	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—VAV3—prostate cancer	0.000357	0.00163	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—FGF10—prostate cancer	0.000357	0.00163	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—RXRA—prostate cancer	0.000354	0.00162	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—KDR—prostate cancer	0.000352	0.00161	CbGpPWpGaD
Prilocaine—Feeling abnormal—Doxorubicin—prostate cancer	0.000348	0.000445	CcSEcCtD
Prilocaine—Nausea—Prednisone—prostate cancer	0.000347	0.000444	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—VAV3—prostate cancer	0.000344	0.00157	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—VAV3—prostate cancer	0.000339	0.00155	CbGpPWpGaD
Prilocaine—Hypersensitivity—Epirubicin—prostate cancer	0.000336	0.00043	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—GSK3B—prostate cancer	0.000336	0.00154	CbGpPWpGaD
Prilocaine—Urticaria—Doxorubicin—prostate cancer	0.000335	0.000429	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—LPL—prostate cancer	0.00033	0.00151	CbGpPWpGaD
Prilocaine—Asthenia—Epirubicin—prostate cancer	0.000327	0.000419	CcSEcCtD
Prilocaine—SCN5A—L1CAM interactions—EGFR—prostate cancer	0.000325	0.00148	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—GSK3B—prostate cancer	0.000323	0.00148	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—ITGB3—prostate cancer	0.000319	0.00146	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—LPL—prostate cancer	0.000317	0.00145	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—GSK3B—prostate cancer	0.000311	0.00142	CbGpPWpGaD
Prilocaine—Hypersensitivity—Doxorubicin—prostate cancer	0.000311	0.000398	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—NCOA2—prostate cancer	0.000311	0.00142	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—MMP2—prostate cancer	0.00031	0.00142	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—MAP2K1—prostate cancer	0.00031	0.00142	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—ITGB3—prostate cancer	0.000307	0.0014	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—LPL—prostate cancer	0.000306	0.0014	CbGpPWpGaD
Prilocaine—Asthenia—Doxorubicin—prostate cancer	0.000303	0.000388	CcSEcCtD
Prilocaine—Dizziness—Epirubicin—prostate cancer	0.000302	0.000386	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—CXCL8—prostate cancer	0.000301	0.00138	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—MMP2—prostate cancer	0.000298	0.00136	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—MAP2K1—prostate cancer	0.000298	0.00136	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—ITGB3—prostate cancer	0.000296	0.00135	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—PPARA—prostate cancer	0.000292	0.00133	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—ITGB3—prostate cancer	0.000291	0.00133	CbGpPWpGaD
Prilocaine—Vomiting—Epirubicin—prostate cancer	0.00029	0.000371	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—CASP3—prostate cancer	0.000289	0.00132	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—MMP2—prostate cancer	0.000288	0.00131	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—MAP2K1—prostate cancer	0.000287	0.00131	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—JAK2—prostate cancer	0.000283	0.00129	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—PPARA—prostate cancer	0.00028	0.00128	CbGpPWpGaD
Prilocaine—Dizziness—Doxorubicin—prostate cancer	0.000279	0.000357	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	0.000278	0.00127	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—LEP—prostate cancer	0.000277	0.00127	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—ERBB2—prostate cancer	0.000272	0.00124	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—JAK2—prostate cancer	0.000272	0.00124	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—KDR—prostate cancer	0.000271	0.00124	CbGpPWpGaD
Prilocaine—Nausea—Epirubicin—prostate cancer	0.000271	0.000347	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—PPARA—prostate cancer	0.00027	0.00124	CbGpPWpGaD
Prilocaine—Vomiting—Doxorubicin—prostate cancer	0.000268	0.000344	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—LEP—prostate cancer	0.000266	0.00122	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—PRKCQ—prostate cancer	0.000264	0.00121	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—JAK2—prostate cancer	0.000262	0.0012	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—NCOA1—prostate cancer	0.000262	0.0012	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—ERBB2—prostate cancer	0.000261	0.00119	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—KDR—prostate cancer	0.000261	0.00119	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—EP300—prostate cancer	0.000259	0.00118	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—LEP—prostate cancer	0.000257	0.00117	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—ERBB2—prostate cancer	0.000252	0.00115	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—KDR—prostate cancer	0.000251	0.00115	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—FGF10—prostate cancer	0.000251	0.00115	CbGpPWpGaD
Prilocaine—Nausea—Doxorubicin—prostate cancer	0.000251	0.000321	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—RXRA—prostate cancer	0.000249	0.00114	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—KDR—prostate cancer	0.000248	0.00113	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—prostate cancer	0.000245	0.00112	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—VAV3—prostate cancer	0.000242	0.00111	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—GSK3B—prostate cancer	0.00024	0.0011	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—INS—prostate cancer	0.000237	0.00108	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—MMP9—prostate cancer	0.000233	0.00107	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—CREBBP—prostate cancer	0.000232	0.00106	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—GSK3B—prostate cancer	0.00023	0.00105	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—INS—prostate cancer	0.000227	0.00104	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—MMP9—prostate cancer	0.000224	0.00102	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—CREBBP—prostate cancer	0.000223	0.00102	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—GSK3B—prostate cancer	0.000222	0.00102	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—MMP2—prostate cancer	0.000222	0.00101	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—MAP2K1—prostate cancer	0.000221	0.00101	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—INS—prostate cancer	0.000219	0.001	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—GSK3B—prostate cancer	0.000219	0.001	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—MMP9—prostate cancer	0.000216	0.000988	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—LPL—prostate cancer	0.000215	0.000983	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—SRC—prostate cancer	0.000215	0.000983	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—CREBBP—prostate cancer	0.000215	0.000981	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—MMP2—prostate cancer	0.000213	0.000972	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—MAP2K1—prostate cancer	0.000213	0.000971	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—FGF2—prostate cancer	0.00021	0.000961	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—VEGFA—prostate cancer	0.00021	0.000957	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—ITGB3—prostate cancer	0.000208	0.00095	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—SRC—prostate cancer	0.000207	0.000944	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—MMP2—prostate cancer	0.000205	0.000938	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—MAP2K1—prostate cancer	0.000205	0.000936	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—MMP2—prostate cancer	0.000202	0.000924	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—FGF2—prostate cancer	0.000202	0.000924	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—MAP2K1—prostate cancer	0.000202	0.000922	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—JAK2—prostate cancer	0.000202	0.000921	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—VEGFA—prostate cancer	0.000201	0.00092	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—SRC—prostate cancer	0.000199	0.00091	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—FGF2—prostate cancer	0.000195	0.000891	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—ERBB2—prostate cancer	0.000194	0.000887	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—VEGFA—prostate cancer	0.000194	0.000887	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—JAK2—prostate cancer	0.000194	0.000885	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—PPARA—prostate cancer	0.00019	0.000869	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—EGFR—prostate cancer	0.000189	0.000861	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—JAK2—prostate cancer	0.000187	0.000854	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—ERBB2—prostate cancer	0.000186	0.000852	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—JAK2—prostate cancer	0.000184	0.000841	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—EGFR—prostate cancer	0.000181	0.000828	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—LEP—prostate cancer	0.00018	0.000824	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—ERBB2—prostate cancer	0.00018	0.000822	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—KRAS—prostate cancer	0.000178	0.000814	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—ERBB2—prostate cancer	0.000177	0.000809	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—KDR—prostate cancer	0.000177	0.000808	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—EGFR—prostate cancer	0.000175	0.000798	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—KRAS—prostate cancer	0.000171	0.000782	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—CTNNB1—prostate cancer	0.00017	0.000776	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—IL6—prostate cancer	0.000169	0.000774	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—MMP9—prostate cancer	0.000166	0.000761	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—KRAS—prostate cancer	0.000165	0.000754	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—CTNNB1—prostate cancer	0.000163	0.000745	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—MMP9—prostate cancer	0.00016	0.000731	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—EP300—prostate cancer	0.000158	0.000721	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—CTNNB1—prostate cancer	0.000157	0.000719	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—GSK3B—prostate cancer	0.000156	0.000714	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—MMP9—prostate cancer	0.000154	0.000705	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—INS—prostate cancer	0.000154	0.000704	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—SRC—prostate cancer	0.000153	0.000701	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—MMP9—prostate cancer	0.000152	0.000694	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—EP300—prostate cancer	0.000152	0.000693	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—CREBBP—prostate cancer	0.000151	0.00069	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—VEGFA—prostate cancer	0.00015	0.000683	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—STAT3—prostate cancer	0.000148	0.000676	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—SRC—prostate cancer	0.000147	0.000674	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—EP300—prostate cancer	0.000146	0.000668	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—IL6—prostate cancer	0.000145	0.000662	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MMP2—prostate cancer	0.000144	0.000659	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MAP2K1—prostate cancer	0.000144	0.000658	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—VEGFA—prostate cancer	0.000144	0.000656	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—STAT3—prostate cancer	0.000142	0.00065	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—SRC—prostate cancer	0.000142	0.00065	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—SRC—prostate cancer	0.00014	0.00064	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—IL6—prostate cancer	0.000139	0.000636	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—VEGFA—prostate cancer	0.000139	0.000633	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—TGFB1—prostate cancer	0.000137	0.000627	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—STAT3—prostate cancer	0.000137	0.000627	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—FGF2—prostate cancer	0.000137	0.000626	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—VEGFA—prostate cancer	0.000136	0.000623	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—EGFR—prostate cancer	0.000135	0.000615	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—IL6—prostate cancer	0.000134	0.000613	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—TGFB1—prostate cancer	0.000132	0.000602	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—JAK2—prostate cancer	0.000131	0.0006	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—EGFR—prostate cancer	0.000129	0.000591	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—TGFB1—prostate cancer	0.000127	0.000581	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—KRAS—prostate cancer	0.000127	0.000581	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—ERBB2—prostate cancer	0.000126	0.000578	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—EGFR—prostate cancer	0.000125	0.000569	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—EGFR—prostate cancer	0.000123	0.000561	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—KRAS—prostate cancer	0.000122	0.000558	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—KRAS—prostate cancer	0.000118	0.000538	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—KRAS—prostate cancer	0.000116	0.00053	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—CTNNB1—prostate cancer	0.000111	0.000505	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MMP9—prostate cancer	0.000108	0.000495	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—IL6—prostate cancer	0.000103	0.000472	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—EP300—prostate cancer	0.000103	0.00047	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—SRC—prostate cancer	0.0001	0.000457	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—IL6—prostate cancer	9.93e-05	0.000454	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—VEGFA—prostate cancer	9.74e-05	0.000445	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—STAT3—prostate cancer	9.64e-05	0.000441	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—IL6—prostate cancer	9.58e-05	0.000438	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—AKT1—prostate cancer	9.54e-05	0.000436	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—IL6—prostate cancer	9.44e-05	0.000431	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—AKT1—prostate cancer	9.16e-05	0.000419	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—TGFB1—prostate cancer	8.94e-05	0.000408	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—AKT1—prostate cancer	8.84e-05	0.000404	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—EGFR—prostate cancer	8.76e-05	0.0004	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—KRAS—prostate cancer	8.28e-05	0.000378	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—IL6—prostate cancer	6.73e-05	0.000308	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—AKT1—prostate cancer	6.21e-05	0.000284	CbGpPWpGaD
